BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 25097214)

  • 1. Evidence-based prescribing: combining network meta-analysis with multicriteria decision analysis to choose among multiple drugs.
    Naci H; van Valkenhoef G; Higgins JP; Fleurence R; Ades AE
    Circ Cardiovasc Qual Outcomes; 2014 Sep; 7(5):787-92. PubMed ID: 25097214
    [No Abstract]   [Full Text] [Related]  

  • 2. Prescribing Statins to Reduce Cardiovascular Disease: 10 Common Misconceptions.
    Schade DS; Shey L; Eaton RP
    Am J Med; 2019 Aug; 132(8):897-899. PubMed ID: 30851261
    [No Abstract]   [Full Text] [Related]  

  • 3. Managing cardiovascular risk factors: the gap between evidence and practice.
    Turnbull F
    PLoS Med; 2005 May; 2(5):e131. PubMed ID: 15916459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of Primary Care Appointment Times and Appropriate Prescribing of Statins for At-Risk Patients.
    Hare AJ; Adusumalli S; Park S; Patel MS
    JAMA Netw Open; 2021 May; 4(5):e219050. PubMed ID: 33974057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prescribing statins in general practice: who decides?
    Steel N; Fleetcroft B; Hassan Y
    Br J Gen Pract; 2017 Jun; 67(659):246-247. PubMed ID: 28546390
    [No Abstract]   [Full Text] [Related]  

  • 6. Why are statin prescribing guidelines for primary prevention not always followed in primary care?
    Hassan Y; Ford J; Steel N; Sheldon J; Fleetcroft R
    Br J Gen Pract; 2016 Oct; 66(651):536-7. PubMed ID: 27688515
    [No Abstract]   [Full Text] [Related]  

  • 7. Variation in minimum desired cardiovascular disease-free longevity benefit from statin and antihypertensive medications: a cross-sectional study of patient and primary care physician perspectives.
    Jaspers NEM; Visseren FLJ; Numans ME; Smulders YM; van Loenen Martinet FA; van der Graaf Y; Dorresteijn JAN
    BMJ Open; 2018 May; 8(5):e021309. PubMed ID: 29804065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Miracle or mirage?
    Learner S
    Nurs Stand; 2007 Aug 1-7; 21(47):18-20. PubMed ID: 17824448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Statins: from data to routine prescription…].
    Vital Durand D
    Rev Med Interne; 2014 Mar; 35(3):151-3. PubMed ID: 24314846
    [No Abstract]   [Full Text] [Related]  

  • 10. Cholesterol drug lowers LDL-C levels but again fails to show clinical benefit.
    Mitka M
    JAMA; 2010 Jan; 303(3):211-2. PubMed ID: 20085945
    [No Abstract]   [Full Text] [Related]  

  • 11. Statin prescribing according to gender, age and indication: what about the benefit-risk balance?
    Wallach-Kildemoes H; Stovring H; Holme Hansen E; Howse K; PĂ©tursson H
    J Eval Clin Pract; 2016 Apr; 22(2):235-46. PubMed ID: 26446680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Should rheumatologists prescribe statins?
    Soubrier M; Bruckert E
    Joint Bone Spine; 2010 Mar; 77(2):93-5. PubMed ID: 20207572
    [No Abstract]   [Full Text] [Related]  

  • 13. Key factors influencing the prescribing of statins: a qualitative study among physicians working in primary healthcare facilities in Indonesia.
    Irawati S; Prayudeni S; Rachmawati R; Wita IW; Willfert B; Hak E; Taxis K
    BMJ Open; 2020 Jun; 10(6):e035098. PubMed ID: 32540888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular risk perception and evidence--practice gaps in Australian general practice (the AusHEART study).
    Heeley EL; Peiris DP; Patel AA; Cass A; Weekes A; Morgan C; Anderson CS; Chalmers JP
    Med J Aust; 2010 Mar; 192(5):254-9. PubMed ID: 20201758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Australian general practitioners initiate statin therapy primarily on the basis of lipid levels; New Zealand general practitioners use absolute risk.
    Schilling C; Knight J; Mortimer D; Petrie D; Clarke P; Chalmers J; Kerr A; Jackson R
    Health Policy; 2017 Dec; 121(12):1233-1239. PubMed ID: 29042060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient and physician factors influence decision-making in hypercholesterolemia: a questionnaire-based survey.
    Krempf M; Simpson RJ; Ramey DR; Brudi P; Giezek H; Tomassini JE; Lee R; Farnier M
    Lipids Health Dis; 2015 May; 14():45. PubMed ID: 25985907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An observational study of how clinicians use cardiovascular risk assessment to inform statin prescribing decisions.
    Robinson T; Jackson R; Wells S; Kerr A; Marshall R
    N Z Med J; 2017 Oct; 130(1463):28-38. PubMed ID: 28981492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of two statin prescribing strategies with respect to adherence and cardiovascular outcomes: observational study.
    Wei L; MacDonald TM; Watson AD; Murphy MJ
    Pharmacoepidemiol Drug Saf; 2007 Apr; 16(4):385-92. PubMed ID: 16998946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inequality in provision of medical care in Sweden: a case of social epidemiological hypochondria?
    Kaufman JS
    J Epidemiol Community Health; 2010 Aug; 64(8):651-2. PubMed ID: 20670974
    [No Abstract]   [Full Text] [Related]  

  • 20. The Preventive-Pill Paradox: How Shared Decision Making Could Increase Cardiovascular Morbidity and Mortality.
    Diprose W; Verster F
    Circulation; 2016 Nov; 134(21):1599-1600. PubMed ID: 27881503
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.